CD8A and Miyoshi myopathy: In a preclinical model of syngeneic stem cell transplant for MM, it was observed that TIGIT immune checkpoint blockade led to the prevention of CD8+ T cell exhaustion and successful immune control of MM, supporting the role of immune system in tumor control (28).